Recently, the board of directors of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. received Mr. Yang Mingyuan's “Resignation Report”. Due to personal reasons, Yang Mingyuan resigned as director, secretary of the board of directors, and head of finance on September 30, 2025, and no longer holds office after leaving office. His departure did not reduce the number of board members below the quorum, did not affect the normal operation of the board of directors, and the application for resignation became effective upon delivery. The company will select and hire a new board secretary and financial director as soon as possible. Until then, the chairman and general manager PANKE will act as board secretary, and director and deputy general manager ZHUANGCHENGFENGJOHN will act as financial director. Yang Mingyuan's direct and indirect shareholding accounts for about 0.13% of the company's total share capital. After leaving office, he will abide by the relevant holdings reduction regulations.

Recently, the board of directors of Jiangsu Yahong Pharmaceutical Technology Co., Ltd. received Mr. Yang Mingyuan's “Resignation Report”. Due to personal reasons, Yang Mingyuan resigned as director, secretary of the board of directors, and head of finance on September 30, 2025, and no longer holds office after leaving office. His departure did not reduce the number of board members below the quorum, did not affect the normal operation of the board of directors, and the application for resignation became effective upon delivery. The company will select and hire a new board secretary and financial director as soon as possible. Until then, the chairman and general manager PANKE will act as board secretary, and director and deputy general manager ZHUANGCHENGFENGJOHN will act as financial director. Yang Mingyuan's direct and indirect shareholding accounts for about 0.13% of the company's total share capital. After leaving office, he will abide by the relevant holdings reduction regulations.